Elkfork Partners’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $120K | Buy |
10,428
+2,398
| +30% | +$27.6K | ﹤0.01% | 923 |
|
|
2019
Q2 | $80K | Buy |
8,030
+1,958
| +32% | +$19.5K | ﹤0.01% | 971 |
|
|
2019
Q1 | $78K | Hold |
6,072
| – | – | ﹤0.01% | 951 |
|
|
2018
Q4 | $92K | Hold |
6,072
| – | – | ﹤0.01% | 904 |
|
|
2018
Q3 | $122K | Hold |
6,072
| – | – | ﹤0.01% | 936 |
|
|
2018
Q2 | $118K | Hold |
6,072
| – | – | ﹤0.01% | 892 |
|
|
2018
Q1 | $122K | Buy |
6,072
+792
| +15% | +$15.9K | ﹤0.01% | 905 |
|
|
2017
Q4 | $70K | Buy |
5,280
+1,188
| +29% | +$15.8K | ﹤0.01% | 968 |
|
|
2017
Q3 | $76K | Buy |
4,092
+1,122
| +38% | +$20.8K | ﹤0.01% | 941 |
|
|
2017
Q2 | $55K | Buy |
2,970
+1,540
| +108% | +$28.5K | ﹤0.01% | 958 |
|
|
2017
Q1 | $32K | Buy |
1,430
+66
| +5% | +$1.48K | ﹤0.01% | 964 |
|
|
2016
Q4 | $47K | Buy |
+1,364
| New | +$47K | ﹤0.01% | 886 |
|